ArticleFrontiers in medicine2025

Plasma cell targeting with the anti-CD38 antibody daratumumab in myalgic encephalomyelitis/chronic fatigue syndrome-a clinical pilot study.

Øystein Fluge et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.